Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document.

Literature DB >> 26009594

Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document.

Bernardo Cortese¹, Juan F Granada², Bruno Scheller³, Peter A Schneider⁴, Gunnar Tepe⁵, Dierk Scheinert⁶, Lawrence Garcia⁷, Eugenio Stabile⁸, Fernando Alfonso⁹, Gary Ansel¹⁰, Thomas Zeller¹¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 26009594 DOI： 10.1093/eurheartj/ehv204

Source DB: PubMed Journal: Eur Heart J ISSN： 0195-668X Impact factor: 29.983

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

Review 1. Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.

Authors: David Marlevi; Elazer R Edelman
Journal: J Am Coll Cardiol Date: 2021-05-18 Impact factor: 24.094

2. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.

Authors: Abhisekh Mohapatra; Zein Saadeddin; Daniel J Bertges; Michael C Madigan; Georges E Al-Khoury; Michel S Makaroun; Mohammad H Eslami
Journal: J Vasc Surg Date: 2019-08-10 Impact factor: 4.268

3. Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients.

Authors: Abraham R Tzafriri; Benny Muraj; Fernando Garcia-Polite; Antonio G Salazar-Martín; Peter Markham; Brett Zani; Anna Spognardi; Mazen Albaghdadi; Steve Alston; Elazer R Edelman
Journal: Biomaterials Date: 2020-08-20 Impact factor: 12.479

Review 4. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.

Authors: Konstantinos Katsanos; Benjamin P Geisler; Abigail M Garner; Hany Zayed; Trevor Cleveland; Jan B Pietzsch
Journal: BMJ Open Date: 2016-05-09 Impact factor: 2.692

5. Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.

Authors: Herman Schroë; Andrew H Holden; Yann Goueffic; Shirley J Jansen; Patrick Peeters; Koen Keirse; Wulf Ito; Frank Vermassen; Antonio Micari; Erwin Blessing; Michael R Jaff; Thomas Zeller
Journal: Catheter Cardiovasc Interv Date: 2017-10-31 Impact factor: 2.692

10. The Development of an ex vivo Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices.

Authors: Kathryn Cooper; Claire V Cawthon; Emily Goel; Marzieh Atigh; Uwe Christians; Saami K Yazdani
Journal: Front Med Technol Date: 2021-06-10

10 in total

Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document.

Review 1. Vascular Lesion-Specific Drug Delivery Systems: JACC State-of-the-Art Review.

2. Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries.

3. Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients.

Review 4. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.

5. Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.

6. A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions.

7. Nanoparticle coatings for controlled release of quercetin from an angioplasty balloon.

Review 8. Drug-coated balloon in superficial femoral artery in-stent restenosis.

9. In vitro and in vivo Assessment of Keratose as a Novel Excipient of Paclitaxel Coated Balloons.

10. The Development of an ex vivo Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices.